Scitech Medical has announced it has begun enrolling patients for the company’s PMCF (SOLARIS Peripheral PMCF Trial) study.
Led by Michel Bosiers (St. Franziskus-Hospital, Münster, Germany) the study is coordinated by the Foundation for Cardiovascular Research and Education and will enrol 70 patients with occlusive disease from sites in Germany, The Netherlands and Italy.
The study aims to evaluate the long-term safety and efficacy of the Solaris vascular stent graft, a flexible and self-expanding endograft which, according to the company, is designed to cover and seal off diseased tissue, providing an endoluminal bypass option for physicians facing complex lesions.
Enrolment started in May 2021 and the final results are expected in May 2023.
